Novavax

Four years after near-death experience, PhIII data bring good news for Novavax
Four years after near-death experience, PhIII data bring good news for Novavax
Endpoints
Novavax
clinical trials
NanoFlu
vaccines
Flag link:
Novavax Receives $4 Million in Funding to Develop a Vaccine for COVID-19
Novavax Receives $4 Million in Funding to Develop a Vaccine for COVID-19
Motley Fool
Novavax
vaccines
CEPI
COVID-19
coronaviruses
Flag link:
Novavax to Begin Clinical Testing of Coronavirus Vaccine by Late Spring
Novavax to Begin Clinical Testing of Coronavirus Vaccine by Late Spring
Motley Fool
Novavax
vaccines
clinical trials
coronaviruses
COVID-19
Flag link:
5 Biotechs to Watch With the Coronavirus Scare
5 Biotechs to Watch With the Coronavirus Scare
Motley Fool
Wuhan Coronavirus
Biocryst
Gilead Sciences
Inovio
Moderna Therapeutics
Novavax
Flag link:
Wuhan Coronavirus Hits the U.S. And Vaccine Stock Soars
Wuhan Coronavirus Hits the U.S. And Vaccine Stock Soars
Motley Fool
Wuhan Coronavirus
China
CDC
vaccines
Novavax
Flag link:
Novavax Wins Fast-Track Designation for Flu Vaccine
Novavax Wins Fast-Track Designation for Flu Vaccine
Motley Fool
Novavax
flu vaccines
vaccines
NanoFlu
FDA
fast track
Flag link:
31 biopharmas at high risk of bankruptcy in 2020
31 biopharmas at high risk of bankruptcy in 2020
Biopharma Dive
bankruptcy
Teva Pharmaceutical
Bausch Health
Novavax
Flag link:
Novavax Begins Phase III Study on Influenza Vaccine Candidate
Novavax Begins Phase III Study on Influenza Vaccine Candidate
Yahoo/Zacks.com
Novavax
vaccines
clinical trials
influenza
NanoFlu
Flag link:
Novavax Takes Accelerated Approval Pathway For Flu Vaccine Development
Novavax Takes Accelerated Approval Pathway For Flu Vaccine Development
Yahoo/Benzinga
Novavax
NanoFlu
vaccines
Flag link:
Catalent picks up Novavax facilities, 100 employees
Catalent picks up Novavax facilities, 100 employees
Biopharma Dive
Paragon Gene Therapy
Catalent
CMO
Novavax
Flag link:
Novavax still plans to push RSV vaccine to market after failed trial
Novavax still plans to push RSV vaccine to market after failed trial
Bizjournals
Novavax
RSV
clinical trials
vaccines
ResVax
Flag link:
The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs
The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs
Yahoo/Benzinga
Wave Life Sciences
Sarepta Therapeutics
Novavax
ContraFect
Scynexis
earnings
Abbott Labs
Intuitive Surgical
Brainsway
Hookipa
Turning Point Therapeutics
IPOs
Flag link:
Does Novavax Have a Viable Path Forward?
Does Novavax Have a Viable Path Forward?
Motley Fool
Novavax
vaccines
ResVax
Flag link:
Can Novavax Convince the FDA Its Vaccine Deserves a Chance?
Can Novavax Convince the FDA Its Vaccine Deserves a Chance?
Motley Fool
Novavax
RSV
vaccines
FDA
clinical trials
Flag link:
Another PhIII RSV failure thumps beleaguered Novavax, but execs claim there's a way forward
Another PhIII RSV failure thumps beleaguered Novavax, but execs claim there's a way forward
Endpoints
RSV
vaccines
Novavax
clinical trials
Flag link:
JP Morgan Healthcare Conference Update: Sage, Mersana, Shutdown Woes and Babies
JP Morgan Healthcare Conference Update: Sage, Mersana, Shutdown Woes and Babies
BioSpace
JPMHC 2019
SAGE Therapeutics
SAGE-217
Mersana
Novavax
Denali Therapeutics
AstraZeneca
Amarin
FDA
government shutdown
Flag link:
The Most Promising Biotech Names Heading Into 2019
The Most Promising Biotech Names Heading Into 2019
Investopedia
biotech
AbbVie
Novavax
Amarin
TG Therapeutics
Flag link:
2 Biotech Stocks Poised for Big Gains in 2019
2 Biotech Stocks Poised for Big Gains in 2019
Motley Fool
Amarin
Vascepa
Novavax
ResVax
Flag link:
Why Novavax Is Up 60% in 2018
Why Novavax Is Up 60% in 2018
Motley Fool
Novavax
NanoFlu
ResVax
vaccines
Flag link:
GlaxoSmithKline to pass $10B in 2024 vaccine sales, with Merck, Sanofi and Pfizer rounding out the top 4: report
GlaxoSmithKline to pass $10B in 2024 vaccine sales, with Merck, Sanofi and Pfizer rounding out the top 4: report
Fierce Pharma
GSK
Merck
Sanofi
Pfizer
Novavax
vaccines
Flag link:

Pages